Search Results 141-150 of 13731 for Assay
... assay development of various types of disorders. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
The purpose of this registry is to collect data that describes the characteristics of people with advanced cancer for whom the Guardant360 assay is ordered and ...
... assays to those obtained by orthogonal methods, including tissue-based assays and results from a ctDNA assay by Guardant on blood. Pagination Clinical ...
He is currently working to develop a cell-based assay that may help determine diagnosis and prognosis for patients with idiopathic neurological symptoms or ...
The purpose of this study is to validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results ...
In collaboration with laboratory technologists, supervisors and genetic counselors, they continually work to improve assays by increasing mutation detection ...
The most widely available assays measuring serum or plasma FGF23 detect the carboxy-terminal fragment. Recently, an assay measuring the biologically active ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
Learn about lead poisoning symptoms and treatment of lead exposure in children and adults. Explore ways to keep your kids safe from lead exposure.
Title: Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1 · Title: Barriers to Mayo Obstetric Care ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.